Addex Therapeutics (ADXN) EBT (2018 - 2026)
Addex Therapeutics (ADXN) posted EBT of -$2.2 million for Q1 2026, up 4.72% sequentially from -$2.3 million in Q4 2025, and down 33.43% YoY from -$3.3 million in Q1 2025.
Addex Therapeutics (ADXN) EBT (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported EBT for 9 years, with the latest figure at -$2.2 million in Q1 2026.
- Quarterly EBT fell 33.43% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.8 million (down 38.42% YoY) and the FY2025 annual result came in at -$8.3 million, down 47.89% from the prior year.
- EBT advanced to -$2.2 million in Q1 2026 per ADXN's latest filing, from -$2.3 million in the prior quarter.
- Over five years, EBT peaked at $6.6 million in Q4 2022 and troughed at -$7.5 million in Q2 2022.
- A 5-year average of -$1.9 million and a median of -$1.8 million in 2024 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2024: EBT jumped 237.36% in 2022, then tumbled 798.08% in 2024.
- Over 5 years, EBT stood at $6.6 million in 2022, then slumped by 115.36% to -$1.0 million in 2023, then sank by 34.16% to -$1.4 million in 2024, then plunged by 68.91% to -$2.3 million in 2025, then climbed by 4.72% to -$2.2 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$2.2 million, -$2.3 million, and -$2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Addex Therapeutics | 515.38 Mn | 515.38 Mn | - | -2.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.19 Mn |
| Dec 31, 2025 | -2.29 Mn |
| Sep 30, 2025 | -1.97 Mn |
| Jun 30, 2025 | -2.37 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | -1.36 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | -1.61 Mn |
| Mar 31, 2024 | -3.59 Mn |
| Dec 31, 2023 | -1.01 Mn |
| Sep 30, 2023 | -804,661.58 |
| Jun 30, 2023 | -579,883.88 |
| Mar 31, 2023 | -400,039.88 |
| Dec 31, 2022 | 6.59 Mn |
| Sep 30, 2022 | -4.25 Mn |
| Jun 30, 2022 | -7.50 Mn |
| Mar 31, 2022 | -5.59 Mn |
| Dec 31, 2021 | -4.80 Mn |
| Sep 30, 2021 | -3.92 Mn |
| Jun 30, 2021 | -5.14 Mn |